Abstract

BackgroundMental illness is highly prevalent among prisoners. Although psychotropic medicines can ameliorate symptoms of mental illness, prescribers in prisons must balance clinical needs against risks to safety and security. Concerns have been raised at the large number of prisoners reportedly receiving psychotropic medicines in England. Nonetheless, unlike for the wider community, robust prescribing data are not routinely available for prisons. We investigated gender-specific patterns in the prevalence and appropriateness of psychotropic prescribing in English prisons.MethodsWe studied 6052 men and 785 women in 11 prisons throughout England. This represented 7.9 % of male and 20.5 % of female prisoners nationally. Using a cross-sectional design, demographic and prescription data were collected from clinical records of all prisoners prescribed psychotropic medicines, including hypnotic, anxiolytic, antipsychotic, anti-manic, antidepressant and Central Nervous System stimulant medications. Percentages and 95 % CIs were used to estimate the prevalence of prescribing. The Prescribing Appropriate Indicators tool was used to determine appropriateness. Prevalence Ratios (PR) were generated to make age-adjusted comparisons between prisoners and the general population using a dataset supplied by the Clinical Practice Research Datalink.ResultsOverall, 47.9 % (CI 44.4–51.4) of women and 16.9 % (CI 16.0–17.9) of men in prison were prescribed one or more psychotropic medicines. Compared with the general population, age-adjusted prescribing prevalence was six times higher among women (PR 5.95 CI 5.36–6.61) and four times higher among men (PR 4.02 CI 3.75–4.30). Undocumented or unapproved indications for prescriptions, not listed in the British National Formulary, were recorded in a third (34.7 %, CI 32.5–37.0) of cases, most commonly low mood and personality disorder.ConclusionsPsychotropic medicines were prescribed frequently in prisons, especially among women, and for a wider range of indications than are currently recommended. These findings raise questions about whether the prescribing of psychotropic medicines in prisons is wholly appropriate and proportionate to the level of clinical need. Prisons need to develop a wider array of treatment responses, other than medicines, to effectively tackle mental illness, challenging behaviours and distress.Electronic supplementary materialThe online version of this article (doi:10.1186/s12888-016-1055-7) contains supplementary material, which is available to authorized users.

Highlights

  • Mental illness is highly prevalent among prisoners

  • This contrast was apparent for women in prison, with over half of women aged 35–54 being prescribed psychotropic medicines compared with less than 10 % of women in the general population

  • The findings of this study showed a high prevalence of psychotropic prescribing in English prisons, with 47.9 % of women and 16.9 % of men prescribed at least one psychotropic medicine

Read more

Summary

Introduction

Mental illness is highly prevalent among prisoners. Psychotropic medicines can ameliorate symptoms of mental illness, prescribers in prisons must balance clinical needs against risks to safety and security. We investigated gender-specific patterns in the prevalence and appropriateness of psychotropic prescribing in English prisons. Complex health needs, with the prevalence of mental illness greatly elevated [1, 2]. Individuals presenting with mental illness may require treatment with psychotropic medicines such as antidepressants, antipsychotics and antimanic drugs. Due to the complex interplay between clinical, social and situational factors, making prescribing decisions in prison can be extremely challenging [8]. Guidance issued by the UK’s professional body for general practitioners has strongly emphasised the need to consider safety and security risks when prescribing in prisons, citing increased risks of illicit substance misuse and trading, comorbidity, self-harm and suicide [9]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.